CONMED Corp — Director's Dealing 2024

Nov 21, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2024-11-20

Reporting Person: Glaze Richard (Chief Information Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-20	Common Stock	M	375	—	Acquired	375	Direct
2024-11-20	Common Stock	F	118	$70.69	Disposed	257	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-11-20	RSUs (Restricted Stock Units)	$0	M	375	Disposed	2033-11-20	Common Stock (375)	Direct

Footnotes

F1: Represents the settlement of vested restricted stock units (RSUs) with the delivery of shares of common stock, subject to withholding for taxes. Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.